Edris Badreddin's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Dec 5, 2024
- Accession no.
- 0001104659-24-125969
- Filed
- Dec 5, 2024
- Trade date
- Dec 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $839.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edris BadreddinCIK 0001786966 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | Common Stock | SSaleDisposed | −11,966 | $41.78 | −$499,939.48 | 217,634 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −8,034 | $42.24 | −$339,356.16 | 209,600 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.